It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Endothelial dysfunction is a key player in both the onset and development of atherosclerosis. No study has examined whether healthy dietary patterns can improve microvascular endothelial function in patients with coronary heart disease (CHD) in the long-term and whether this relationship can affect patient’s risk of CHD recurrence. In the CORDIOPREV study, a randomized, double-blind, controlled trial, dietary intervention with either the Mediterranean diet or a low-fat diet was implemented in 1,002 CHD patients. A laser-doppler flowmetry was performed at baseline and after 6 years of follow up in 664 patients, evaluating the effects of this dietary intervention on microvascular basal flow and reactive hyperaemia area, as well as on the risk of CHD recurrence, based on the TRS2P risk score. Basal flow (97.78 ± 2.79 vs. 179.31 ± 5.06 arbitrary perfusion units, 83.38% increase, p < 0.001) and reactive hyperaemia area (4233.3 ± 127.73 vs. 9695.9 ± 205.23 arbitrary perfusion units per time, 129.04% increase, p < 0.001) improved after the dietary intervention in the cohort, without finding differences due to the diet (p > 0.05 for the diet-effect). When patients were stratified to low, moderate or high-risk of recurrence, basal flow was similarly increased in all three groups. However, reactive hyperaemia area was improved to a greater extent in patients at the low-risk group compared with those at moderate or high-risk. No differences were observed between diets. Healthy dietary patterns can improve microvascular endothelial function and this improvement persists in the long-term. Patients with a low-risk of CHD recurrence show a greater improvement in reactive vasodilation to ischemia than patients in the moderate or high-risk groups.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Reina Sofia University Hospital, Lipids and Atherosclerosis Unit, Internal Medicine Unit, Cordoba, Spain (GRID:grid.411349.a) (ISNI:0000 0004 1771 4667)
2 Reina Sofia University Hospital, Lipids and Atherosclerosis Unit, Internal Medicine Unit, Cordoba, Spain (GRID:grid.411349.a) (ISNI:0000 0004 1771 4667); Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Cordoba, Spain (GRID:grid.428865.5) (ISNI:0000 0004 0445 6160); University of Cordoba, Department of Medical and Surgical Sciences, Cordoba, Spain (GRID:grid.411901.c) (ISNI:0000 0001 2183 9102); Instituto de Salud Carlos III, CIBER Fisiopatologia de La Obesidad y Nutricion (CIBEROBN), Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427)
3 Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Cordoba, Spain (GRID:grid.428865.5) (ISNI:0000 0004 0445 6160); Instituto de Salud Carlos III, CIBER Fisiopatologia de La Obesidad y Nutricion (CIBEROBN), Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427); University of Cordoba, Department of Cell Biology, Physiology, and Immunology, Cordoba, Spain (GRID:grid.411901.c) (ISNI:0000 0001 2183 9102)
4 Reina Sofia University Hospital, Biochemical Laboratory, Córdoba, Spain (GRID:grid.411349.a) (ISNI:0000 0004 1771 4667)
5 AHEPA University Hospital, First Department of Internal Medicine, Diabetes Center, Division of Endocrinology and Metabolism, Thessaloniki, Greece (GRID:grid.411222.6) (ISNI:0000 0004 0576 4544)